South Africa and Zambia are grappling with a significant challenge in rolling out lenacapavir, a new six-monthly HIV prevention injection. Despite high demand and promising early…

For the first time, Merck has granted generic manufacturers, including three African companies, permission to produce an investigational monthly HIV prevention pill, alimatravir,…

South Africa has launched lenacapavir, a groundbreaking HIV prevention medicine, marking a significant moment in the country's fight against the epidemic. This article reflects…